2020-01-08
Published Date
Life Science
Industry
99
Pages
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chronic Obstructive Pulmonary Disorder market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chronic Obstructive Pulmonary Disorder market segmented into
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Based on the end-use, the global Chronic Obstructive Pulmonary Disorder market classified into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on geography, the global Chronic Obstructive Pulmonary Disorder market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISORDER INDUSTRY
2.1 Summary about Chronic Obstructive Pulmonary Disorder Industry
2.2 Chronic Obstructive Pulmonary Disorder Market Trends
2.2.1 Chronic Obstructive Pulmonary Disorder Production & Consumption Trends
2.2.2 Chronic Obstructive Pulmonary Disorder Demand Structure Trends
2.3 Chronic Obstructive Pulmonary Disorder Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Short-Acting Bronchodilators
4.2.2 Corticosteroids
4.2.3 Methylxanthines
4.2.4 Long-Acting Bronchodilators
4.2.5 Phosphodiesterase-4 Inhibitors
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Short-Acting Bronchodilators
5.2.2 Corticosteroids
5.2.3 Methylxanthines
5.2.4 Long-Acting Bronchodilators
5.2.5 Phosphodiesterase-4 Inhibitors
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Short-Acting Bronchodilators
6.2.2 Corticosteroids
6.2.3 Methylxanthines
6.2.4 Long-Acting Bronchodilators
6.2.5 Phosphodiesterase-4 Inhibitors
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Short-Acting Bronchodilators
7.2.2 Corticosteroids
7.2.3 Methylxanthines
7.2.4 Long-Acting Bronchodilators
7.2.5 Phosphodiesterase-4 Inhibitors
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Short-Acting Bronchodilators
8.2.2 Corticosteroids
8.2.3 Methylxanthines
8.2.4 Long-Acting Bronchodilators
8.2.5 Phosphodiesterase-4 Inhibitors
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Short-Acting Bronchodilators
9.2.2 Corticosteroids
9.2.3 Methylxanthines
9.2.4 Long-Acting Bronchodilators
9.2.5 Phosphodiesterase-4 Inhibitors
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Retail Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca
10.1.2 Boehringer Ingelheim
10.1.3 GSK
10.1.4 Novartis
10.1.5 Teva Pharmaceuticals
10.1.6 Ache Laboratorios Farmaceuticos
10.1.7 Almirall
10.1.8 Aquinox Pharmaceuticals
10.1.9 Ario Pharma
10.1.10 Asmacure
10.1.11 Astellas Pharma
10.1.12 BioMarck Pharmaceuticals
10.2 Chronic Obstructive Pulmonary Disorder Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca
10.2.2 Boehringer Ingelheim
10.2.3 GSK
10.2.4 Novartis
10.2.5 Teva Pharmaceuticals
10.2.6 Ache Laboratorios Farmaceuticos
10.2.7 Almirall
10.2.8 Aquinox Pharmaceuticals
10.2.9 Ario Pharma
10.2.10 Asmacure
10.2.11 Astellas Pharma
10.2.12 BioMarck Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Chronic Obstructive Pulmonary Disorder Product Type Overview
Table Chronic Obstructive Pulmonary Disorder Product Type Market Share List
Table Chronic Obstructive Pulmonary Disorder Product Type of Major Players
Table Brief Introduction of AstraZeneca
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of GSK
Table Brief Introduction of Novartis
Table Brief Introduction of Teva Pharmaceuticals
Table Brief Introduction of Ache Laboratorios Farmaceuticos
Table Brief Introduction of Almirall
Table Brief Introduction of Aquinox Pharmaceuticals
Table Brief Introduction of Ario Pharma
Table Brief Introduction of Asmacure
Table Brief Introduction of Astellas Pharma
Table Brief Introduction of BioMarck Pharmaceuticals
Table Products & Services of AstraZeneca
Table Products & Services of Boehringer Ingelheim
Table Products & Services of GSK
Table Products & Services of Novartis
Table Products & Services of Teva Pharmaceuticals
Table Products & Services of Ache Laboratorios Farmaceuticos
Table Products & Services of Almirall
Table Products & Services of Aquinox Pharmaceuticals
Table Products & Services of Ario Pharma
Table Products & Services of Asmacure
Table Products & Services of Astellas Pharma
Table Products & Services of BioMarck Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chronic Obstructive Pulmonary Disorder Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chronic Obstructive Pulmonary Disorder Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chronic Obstructive Pulmonary Disorder Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chronic Obstructive Pulmonary Disorder Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Chronic Obstructive Pulmonary Disorder Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Obstructive Pulmonary Disorder Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Obstructive Pulmonary Disorder Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Obstructive Pulmonary Disorder Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Obstructive Pulmonary Disorder Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Obstructive Pulmonary Disorder Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Obstructive Pulmonary Disorder Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Corticosteroids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Methylxanthines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Phosphodiesterase-4 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Corticosteroids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Methylxanthines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Phosphodiesterase-4 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Corticosteroids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Methylxanthines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Phosphodiesterase-4 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Corticosteroids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Methylxanthines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Phosphodiesterase-4 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Corticosteroids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Methylxanthines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Phosphodiesterase-4 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Short-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Corticosteroids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Methylxanthines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-Acting Bronchodilators Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Phosphodiesterase-4 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of AstraZeneca 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of GSK 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Teva Pharmaceuticals 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Ache Laboratorios Farmaceuticos 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Almirall 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Aquinox Pharmaceuticals 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Ario Pharma 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Asmacure 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of Astellas Pharma 2017-2020e
Figure Chronic Obstructive Pulmonary Disorder Sales Revenue (Million USD) of BioMarck Pharmaceuticals 2017-2020e